Sucrase-isomaltase deficiency, congenital
|
0.790 |
Biomarker
|
disease |
CTD_human |
|
|
|
Malabsorption Syndrome
|
0.130 |
Biomarker
|
group |
HPO |
|
|
|
Diarrhea
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nephrolithiasis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Malabsorption, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Malabsorption
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of metabolism/homeostasis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Glycogen storage disease type II
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
If compared with infantile AMD (Pompe's disease) our cases have a much higher residual acid alpha-glucosidase activity and show the presence of an antigenically detectable protein.
|
60470 |
1976 |
Generalized glycogen storage disease of infants
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
If compared with infantile AMD (Pompe's disease) our cases have a much higher residual acid alpha-glucosidase activity and show the presence of an antigenically detectable protein.
|
60470 |
1976 |
Cystic Fibrosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Moreover, alpha-glucosidase levels in cystic fibrosis patients correlated with the degree of clinical impairment as measured by the Schwachman score.
|
110502 |
1979 |
Glycogen storage disease type II
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
alpha-glucosidase activity in human leucocytes: choice of lymphocytes for the diagnosis of Pompe's disease and the carrier state.
|
361294 |
1978 |
Generalized glycogen storage disease of infants
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
alpha-glucosidase activity in human leucocytes: choice of lymphocytes for the diagnosis of Pompe's disease and the carrier state.
|
361294 |
1978 |
Glycogen storage disease type II
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Hybrids between thymidine kinase-deficient mouse cells and fibroblasts from a patient with Pompe disease that contained human chromosome 17 were found not to express human acid alpha-glucosidase.
|
388444 |
1979 |
Generalized glycogen storage disease of infants
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Hybrids between thymidine kinase-deficient mouse cells and fibroblasts from a patient with Pompe disease that contained human chromosome 17 were found not to express human acid alpha-glucosidase.
|
388444 |
1979 |
Glycogen storage disease type II
|
0.100 |
Biomarker
|
disease |
BEFREE |
The lysosomal enzyme acid alpha glucosidase (GAA) or acid maltase is deficient in glycogen storage disease type II.
|
1684505 |
1991 |
Generalized glycogen storage disease of infants
|
0.100 |
Biomarker
|
disease |
BEFREE |
The lysosomal enzyme acid alpha glucosidase (GAA) or acid maltase is deficient in glycogen storage disease type II.
|
1684505 |
1991 |
Adenocarcinoma
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Thus, the specificity and ubiquity of sucrase-isomaltase expression in adenocarcinomas of the colon can be exploited to improve the clinical management of this disease.
|
1707385 |
1991 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
In addition, all colon carcinoma metastases examined were positive for sucrase-isomaltase.
|
1707385 |
1991 |
Adenocarcinoma of colon
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
This study shows that the expression of enzymatically active sucrase-isomaltase is a ubiquitous property of primary and metastatic colon adenocarcinoma.
|
1707385 |
1991 |
Secondary Neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
In addition, all colon carcinoma metastases examined were positive for sucrase-isomaltase.
|
1707385 |
1991 |
Glycogen storage disease type II
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These studies emphasize the effect of allelic diversity on the level of residual acid alpha-glucosidase activity and on the clinical course of glycogenosis type II.
|
2403755 |
1990 |
Generalized glycogen storage disease of infants
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These studies emphasize the effect of allelic diversity on the level of residual acid alpha-glucosidase activity and on the clinical course of glycogenosis type II.
|
2403755 |
1990 |
Glycogen storage disease type II
|
0.100 |
Biomarker
|
disease |
BEFREE |
First trimester diagnosis of Pompe's disease (glycogenosis type II) with normal outcome: assay of acid alpha-glucosidase in chorionic villous biopsy using antibodies.
|
3098466 |
1986 |
Generalized glycogen storage disease of infants
|
0.100 |
Biomarker
|
disease |
BEFREE |
First trimester diagnosis of Pompe's disease (glycogenosis type II) with normal outcome: assay of acid alpha-glucosidase in chorionic villous biopsy using antibodies.
|
3098466 |
1986 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A unique family is presented which consists of a patient with the juvenile muscular dystrophy form of glycogenosis type II and four healthy individuals, both parents and sisters, with low acid alpha-glucosidase activity.
|
3282727 |
1988 |